Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of GC3110A in Healthy Adults
NCT02121782Phase 2Completed
- Sponsor
- GC Biopharma
- Start
- May 2014
- Primary completion
- Jun 2014
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GC Flu Quadrivalent in influenza, sponsored by GC Biopharma. Started May 2014; status: completed.
02
Drugs
GC Flu Quadrivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02121782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02121782.